Prothena Stock Price (NASDAQ:PRTA)

Add to My Stocks
$49.74 $0.04 (0.08%) PRTA stock closing price Jan 23, 2017 (Closing)
YOUR DAILY UPDATE ON
PRTA
Prothena
23 JAN 2017
amigobulls logo
PRTA hand_up
PRTA vs S&P 500
Closing Price: Jan 23, 2017
PRTA
$49.74 ( -0.08%)
S&P 500
2265.2 ( -0.27%)
PRTA
52 Week Price Range
1 Year Return: 21.5%
Q3 Growth*
Poor
Profitable ?
No
net image
2016 Q3 Net Loss
-11280.8%
home image
Rating
PRTA POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Prothena Snapshot Video

11 5 2

PRTA Stock Details

Prev Close* : $49.78
Market Cap:
$1.72B
Day Low: $48.31
52 Week Low: $28.20
Open: $49.78
Volume: 253950
Day High: $50.3
52 Week High: $68.18
Dividend:
N/A

Latest Stock Market News

Latest Articles

Prothena News - From Partners

PRTA Stockcharts

View PRTA PE ratio, PS ratio stocks charts and compare with peers.
PRTA Chart
Note: Compare Prothena stock price history with the index and industry peers.

Prothena Valuation

PS ratio (
price to sales ratio
)
1426.29
PB ratio (
price to book ratio
)
4.2

Prothena Financial Ratios

Receivables Turnover
1.95

PRTA Industry Peers

Company Price Change (%)
Cambrex (CBM)52.841.2 (2.22%)
Spark Therapeutics (ONCE)57.630.39 (0.68%)
Roche Holdings (RHHBY)29.20.01 (0.03%)
Neuroderm (NDRM)23.050.2 (0.88%)
Voyager Therapeutics (VYGR)11.050.25 (2.21%)
Cynapsus Therapeutics (CYNA)40.480 (0%)
Intec Pharma (NTEC)5.40.1 (1.89%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MannKind (MNKD)0.690.05 (7.84%)
Trevena (TRVN)6.570.38 (6.14%)
Cara Therapeutics (CARA)11.950.52 (4.55%)
China Biologic Products (CBPO)111.213.89 (3.62%)
Arna Pharma (ARNA)1.40.03 (2.19%)
Enzo Biochem (ENZ)6.950.14 (2.06%)
Exelixis (EXEL)18.290.37 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jan 23, 2017
CompanyPriceChange (%)
Fate Therapeutics (FATE)2.740.32 (10.46%)
Kamada (KMDA)5.7740.33 (5.41%)
Nymox Pharmaceutical (NYMX)2.950.16 (5.14%)
Inovio Pharma (INO)5.980.3 (4.78%)
Intercept Pharma (ICPT)105.224.92 (4.47%)
VIVUS (VVUS)1.140.05 (4.2%)
Sangamo BioSciences (SGMO)3.50.15 (4.11%)
Top losers from Medical-Biomed-Genetics industry
* As of Jan 23, 2017

Prothena Financial Statements

income statement20152014201320122011
Net Sales Or Revenues1.6M50.85M0.67M2.65M0.5M
Net Income-80.61M-7.15M-40.99M-41.41M-29.67M
Total Operating Expense81.53M57.5M41.1M44.05M29.74M
view Prothena Corporation PLC income statement
balance sheet20152014201320122011
Total Assets385.23M304.11M182.41M129.28M3.61M
Total Liabilities24.56M14.22M9.14M2.79M10.05M
Shareholders Equity360.66M289.88M173.27M126.48M-6.43M
view Prothena Corporation PLC balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities11.47M1.37M5.67M-7.22M6.61M
Net Cash From (Used By) Operating Activities-62.45M-0.68M-32.09M-42.07M-19.69M
Increase (Decrease) In Prop Plant And Equipment-1.38M-0.49M-0.53M-1.3M-0.51M
view Prothena Corporation PLC cashflow statement

Prothena Corporation PLC Stock News - Partner Headlines

Prothena Stock Message Board

Prothena stock price ended the last trading day at 49.78. The total market value as denoted by 1.69B for Prothena, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Prothena stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Prothena is worth a lot, it will most likely be reflected in an inflated Prothena stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Prothena stock quote data shows the number of shares traded. For Ex: 373136 Prothena shares were traded as of last trading day, as seen from Prothena stock chart. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Prothena does not pay dividends. Prothena stock price history, gives the entire historical data for PRTA stock.